Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Grohar

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2023
Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031Thomas Cash, Mark D Krailo, Allen B Buxton, et al.
EMBO Molecular Medicine|December 17, 2020
Mithramycin induces promoter reprogramming and differentiation of rhabdoid tumorMaggie H Chasse, Benjamin K Johnson, Elissa A Boguslawski, et al.
Cell Reports|January 19, 2016
Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing SarcomaPatrick J Grohar, Suntae Kim, Guillermo O Rangel Rivera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2024
Cell Context Is the Third Axis of Synergy for the Combination of ATR Inhibition and Cisplatin in Ewing SarcomaJennifer Jess, Katie M Sorensen, Elissa A Boguslawski, et al.
Pediatric Blood & Cancer|August 29, 2025
New Approaches to Investigate Novel Agents in Ewing Sarcoma: A Report From the Children's Oncology Group Bone Tumor CommitteeJessica D Daley, Susan L Whiteway, Christine M Heske, et al.
Cancer Research|October 5, 2016
Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the NucleusMatt L Harlow, Nichole Maloney, Joseph Roland, et al.
Cell Reports|June 15, 2022
Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1Qu Deng, Ramakrishnan Natesan, Florencia Cidre-Aranaz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2016
Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription FactorChristy L Osgood, Nichole Maloney, Christopher G Kidd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2025
Molecular Characterization Informs Prognosis in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology GroupRiaz Gillani, David S Shulman, Natalie J DelRocco, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology GroupRiaz Gillani, David S Shulman, Natalie J DelRocco, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2023
Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031Thomas Cash, Mark D Krailo, Allen B Buxton, et al.
EMBO Molecular Medicine|December 17, 2020
Mithramycin induces promoter reprogramming and differentiation of rhabdoid tumorMaggie H Chasse, Benjamin K Johnson, Elissa A Boguslawski, et al.
Cell Reports|January 19, 2016
Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing SarcomaPatrick J Grohar, Suntae Kim, Guillermo O Rangel Rivera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2024
Cell Context Is the Third Axis of Synergy for the Combination of ATR Inhibition and Cisplatin in Ewing SarcomaJennifer Jess, Katie M Sorensen, Elissa A Boguslawski, et al.
Pediatric Blood & Cancer|August 29, 2025
New Approaches to Investigate Novel Agents in Ewing Sarcoma: A Report From the Children's Oncology Group Bone Tumor CommitteeJessica D Daley, Susan L Whiteway, Christine M Heske, et al.
Cancer Research|October 5, 2016
Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the NucleusMatt L Harlow, Nichole Maloney, Joseph Roland, et al.
Cell Reports|June 15, 2022
Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1Qu Deng, Ramakrishnan Natesan, Florencia Cidre-Aranaz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2016
Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription FactorChristy L Osgood, Nichole Maloney, Christopher G Kidd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2025
Molecular Characterization Informs Prognosis in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology GroupRiaz Gillani, David S Shulman, Natalie J DelRocco, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology GroupRiaz Gillani, David S Shulman, Natalie J DelRocco, et al.
Pageof 5